KalVista Pharmaceuticals, Inc.KALVNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor KALV?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor KALV

Key Statistics

About

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Thomas Crockett

kalvista.com/ →

News

Indian Banks Prep For New Provisioning Norms With Strong Asset Quality, Capital

seekingalpha.com

Customers Bancorp: A Growth Bank Story With Legs

seekingalpha.com

Travel Vaccines Market Size to Reach USD 10.69 Billion by 2033, Driven by Rising International Travel and Preventive Healthcare Awareness – SNS Insider.

globenewswire.com

Penicillin Drug Market Analysis and Growth Forecast Report 2026-2031: Government Support, Narrow-Spectrum Focus, and China-Centric Supply Volatility Influence Market Dynamics

globenewswire.com

MMORPG Gaming Trends, Statistics, and Growth Forecasts 2026-2031: Monetization Innovation, Government Support, and Regulatory Oversight Shape The Future $50+ Billion Industry

globenewswire.com

Cynomi Accelerates UK and EU Regulatory Governance Offerings for MSPs and MSSPs as Customer Requirements Intensify

globenewswire.com

Pharmaceutical Contract Development and Manufacturing Organization Forecasts Report 2026: A $374.68 Billion Market by 2031 - One-Stop CDMOs, Rapid AI Platforms, and GLP-1/HPAPI Build-Outs Drive Demand

globenewswire.com

GXO Partners with London Luton Airport to Operate its First Consolidation Centre

globenewswire.com

Aegis Critical Energy Defence Announces Formation of Homeland Nuclear Energy Inc. to Spearhead Advanced SMR and Micro-Reactor Integration

newsfilecorp.com

SeenThis and Lumen Research Launch Attention Measurement Model Powered by SeenThis Adaptive Streaming

globenewswire.com

PreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive breakthroughs in precision cancer treatment

globenewswire.com

Milepost establish every-day charging in Norrköping in cooperation with Norrköping Municipality

globenewswire.com

Milepost etablerar vardagsladdning i Norrköping i samarbete med Norrköpings Kommun

globenewswire.com

11:11 Systems kondigt partnerprijzen 2025 aan voor het VK en Europa

globenewswire.com

Aptean Launches Paragon Route 360 on AppCentral, Transforming AI-Driven Real-Time Routing and Scheduling for Logistics Teams

globenewswire.com

Aptean Launches Paragon Route 360 on AppCentral, Transforming AI-Driven Real-Time Routing and Scheduling for Logistics Teams

globenewswire.com

Houlihan Lokey Expands Specialty Distribution Capabilities With Senior European Hires

businesswire.com

CRCAM Brie Picardie - déclaration hebdomadaire - Rachats réalisés dans les conditions de l'article 5 du Règlement MAR

globenewswire.com

Global Chocolate Market Trends 2031 Report: Premium Products and Health-Conscious Consumers Driving Growth, Says a 2026 Mordor Intelligence Report

globenewswire.com

2 Stocks With Monster Upside Over the Next 10 Years

fool.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance